@ Charité in #Berlin
Likes: improving science & improv comedy
#EpiSky #Epidemiology #HigherEd #AcademicSky
Agree?
Follow: bsky.app/profile/appl...
Spoiler: Edition #3 in the making for Q2 2026! Stay tuned!
Agree?
Follow: bsky.app/profile/appl...
Spoiler: Edition #3 in the making for Q2 2026! Stay tuned!
We’re building a cross-discipline network for people like you, and we’d love your help reaching more folks. If you know contacts or places—like groups, mailing lists, or platforms—where we can share our invite, please DM me! Thanks!!
We’re building a cross-discipline network for people like you, and we’d love your help reaching more folks. If you know contacts or places—like groups, mailing lists, or platforms—where we can share our invite, please DM me! Thanks!!
Lighthearted dice rolling 🎲 before the big reveal. Puzzled looks. Then 🤯 shock, as the implications for their research fields sank in. You could hear a pin drop during the compelling lecture that followed! 👏🏻
Lighthearted dice rolling 🎲 before the big reveal. Puzzled looks. Then 🤯 shock, as the implications for their research fields sank in. You could hear a pin drop during the compelling lecture that followed! 👏🏻
#EuroCIM2025
#EuroCIM2025
Tough to do at 5pm, but @dingdingpeng.the100.ci is a pro!
Tough to do at 5pm, but @dingdingpeng.the100.ci is a pro!
Elise Dumas presented "Inference on sustained treatment strategies, with a case study on young women with breast cancer" on behalf of colleagues from EPFL and France. Lots of interesting stuff to unpack here!...
Elise Dumas presented "Inference on sustained treatment strategies, with a case study on young women with breast cancer" on behalf of colleagues from EPFL and France. Lots of interesting stuff to unpack here!...
This poster looks at "competing confounding", that is...
This poster looks at "competing confounding", that is...